Antibody phenotypes and probabilistic seroprevalence estimates during the emergence of SARS-CoV-2 in Sweden

Autor: Dopico, X., Hanke, L., Sheward, D., Christian, M., Muschiol, S., Grinberg, N., Adori, M., Vidakovics, L., Kim, C., Khoenkhoen, S., Pushparaj, P., Morro, A., Mandolesi, M., Forsell, M., Coquet, J., Corcoran, M., Rorbach, J., Aleman, S., Bogdanovic, G., McInerney, G., Allander, T., Wallace, C., Murrell, B., Albert, J., Karlsson Hedestam, G.

Publikováno v: medRxiv

Serological studies are critical for understanding pathogen-specific immune responses and informing public health measures1,2. Here, we evaluate tandem IgM, IgG and IgA responses in a cohort of individuals PCR+ for SARS-CoV-2 RNA (n=105) representing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1874::8872ef9051a995e6bfcbd6db8e193f8f
https://hdl.handle.net/21.11116/0000-000B-3F3D-C

Seropositivity in blood donors and pregnant women during the first year of SARS‐CoV‐2 transmission in Stockholm, Sweden

Autor: Castro Dopico, X., Muschiol, S., Christian, M., Hanke, L., Sheward, D. J., Grinberg, N. F., Rorbach, J., Bogdanovic, G., Mcinerney, G. M., Allander, T., Wallace, C., Murrell, B., Albert, J., Karlsson Hedestam, G. B.

Background: In Sweden, social restrictions to contain SARS‐CoV‐2 have primarily relied upon voluntary adherence to a set of recommendations. Strict lockdowns have not been enforced, potentially affecting viral dissemination. To understand the lev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c90c3dfbc08ad303de86394a509d2e13

Fine-mapping the immunodominant antibody epitopes on consensus sequence-based HIV-1 envelope trimer vaccine candidates.

Autor: Reiss EIMM; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Meibergdreef 9, Amsterdam, The Netherlands., van Haaren MM; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Meibergdreef 9, Amsterdam, The Netherlands., van Schooten J; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Meibergdreef 9, Amsterdam, The Netherlands., Claireaux MAF; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Meibergdreef 9, Amsterdam, The Netherlands., Maisonnasse P; Université Paris-Saclay - CEA - INSERM U1184, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France., Antanasijevic A; Department of Integrative Structural and Computational Biology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA., Allen JD; School of Biological Sciences, University of Southampton, Southampton, UK., Bontjer I; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Meibergdreef 9, Amsterdam, The Netherlands., Torres JL; Department of Integrative Structural and Computational Biology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA., Lee WH; Department of Integrative Structural and Computational Biology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA., Ozorowski G; Department of Integrative Structural and Computational Biology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA., Vázquez Bernat N; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Kaduk M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Aldon Y; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Meibergdreef 9, Amsterdam, The Netherlands., Burger JA; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Meibergdreef 9, Amsterdam, The Netherlands., Chawla H; School of Biological Sciences, University of Southampton, Southampton, UK., Aartse A; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Meibergdreef 9, Amsterdam, The Netherlands.; Department of Virology, Biomedical Primate Research Centre, Rijswijk, the Netherlands., Tolazzi M; Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy., Gao H; Department of Surgery, Duke University Medical Center, Durham, NC, USA., Mundsperger P; Polymun Scientific Immunbiologische Forschung GmbH, Klosterneuburg, Austria., Crispin M; School of Biological Sciences, University of Southampton, Southampton, UK., Montefiori DC; Department of Surgery, Duke University Medical Center, Durham, NC, USA., Karlsson Hedestam GB; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Scarlatti G; Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy., Ward AB; Department of Integrative Structural and Computational Biology, Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA., Le Grand R; Université Paris-Saclay - CEA - INSERM U1184, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France., Shattock R; Division of Mucosal Infection and Immunity, Department of Medicine, Imperial College of Science, Technology and Medicine, London, UK., Dereuddre-Bosquet N; Université Paris-Saclay - CEA - INSERM U1184, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France., Sanders RW; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Meibergdreef 9, Amsterdam, The Netherlands.; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, USA., van Gils MJ; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Meibergdreef 9, Amsterdam, The Netherlands. m.j.vangils@amsterdamumc.nl.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2022 Nov 25; Vol. 7 (1), pp. 152. Date of Electronic Publication: 2022 Nov 25.